Related Experiment Video
Updated: Feb 4, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Bifurcation analysis of insulin regulated mTOR signalling pathway in cancer cells
1Centre for Computational Biology, Indraprastha Institute of Information Technology-Delhi, Okhla Phase-III, New Delhi, India. sriramk@iiitd.ac.in.
Abstract:
Insulin induced mTOR signalling pathway is a complex network implicated in many types of cancers. The molecular mechanism of this pathway is highly complex and the dynamics is tightly regulated by intricate positive and negative feedback loops. In breast cancer cell lines, metformin has been shown to induce phosphorylation at specific serine sites in insulin regulated substrate of mTOR pathway that results in apoptosis over cell proliferation. The author models and performs bifurcation analysis to simulate cell proliferation and apoptosis in mTOR signalling pathway to capture the dynamics both in the presence and absence of metformin in cancer cells. Metformin is shown to negatively regulate PI3K through AMPK induced IRS1 phosphorylation and this brings about a reversal of AKT bistablity in codimension-1 bifurcation diagram from S-shaped, related to cell proliferation in the absence of drug metformin, to Z-shaped, related to apoptosis in the presence of drug metformin. The author hypothesises and explains how this negative regulation acts a circuit breaker, as a result of which mTOR network favours apoptosis of cancer cells over its proliferation. The implication of reversing the shape of bistable dynamics from S to Z or vice-versa in biological networks in general is discussed.
Insights
Metformin reverses the mTOR pathway
Area of Science:
- Oncology
- Systems Biology
- Biophysics
Background:
- The insulin-induced mTOR signaling pathway is a complex network involved in cancer.
- This pathway's dynamics are regulated by intricate feedback loops.
- Metformin has been observed to induce apoptosis in breast cancer cells.
Purpose of the Study:
- To model and analyze the dynamics of the mTOR signaling pathway.
- To investigate the effect of metformin on cell proliferation and apoptosis.
- To understand the molecular mechanisms underlying metformin's action in cancer cells.
Main Methods:
- Mathematical modeling and bifurcation analysis were employed.
- The study simulated mTOR pathway dynamics with and without metformin.
- Specific phosphorylation events and their impact on pathway bistability were analyzed.
Main Results:
- Metformin negatively regulates PI3K via AMPK-induced IRS1 phosphorylation.
- This leads to a switch in AKT bistability from S-shaped (proliferation) to Z-shaped (apoptosis).
- Metformin acts as a circuit breaker, promoting cancer cell apoptosis over proliferation.
Conclusions:
- Metformin effectively reverses the mTOR network's dynamics towards apoptosis.
- The study provides insights into the circuit breaker mechanism of metformin.
- The findings have implications for understanding and manipulating biological network dynamics in cancer therapy.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Insulin: The Receptor and Signaling Pathways
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

